An understanding of how Aβ peptides lead to senile plaque formation was revealed through familial genetic studies of AD, which identified dominant mutations in APP and presenilin 1 and presenilin 2; the core catalytic components of γ-secretase (Holtzman et al., 2011; van der Kant and Goldstein, 2015). This evidence concerns the gene APP and Alzheimer disease.